Max Bayer - Journalist Profile | Connect with top journalists

Beats

Biography

Content

Total articles 1235

• Available on paid plans

  CDC advisors broaden RSV vaccine recommendations to at-risk adults in their 50s

  By Max Bayer Verified

  Apr. 16, 2025

• Available on paid plans

  CMS would absorb 340B drug discount program under leaked HHS reorganization proposal

  By Max Bayer Verified

  Apr. 17, 2025

• Available on paid plans

  CMS would absorb 340B drug discount program under leaked HHS reorganization proposal

  By Max Bayer Verified

  Apr. 17, 2025

As seen in

Company Info

Endpoints News

Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.